3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
355
Neoplasms
252
Carcinoma, Non-Small-Cell Lung
199
Colorectal Neoplasms
181
Lung Neoplasms
151
Prostatic Neoplasms
150
Carcinoma, Hepatocellular
127
Leukemia, Myeloid, Acute
96
Pancreatic Neoplasms
86
Multiple Myeloma
82
Neoplasm Metastasis
73
Recurrence
72
Uterine Cervical Neoplasms
68
Rectal Neoplasms
68
Ovarian Neoplasms
65
Stomach Neoplasms
64
Triple Negative Breast Neoplasms
59
Squamous Cell Carcinoma of Head and Neck
57
Brain Neoplasms
56
Head and Neck Neoplasms
55
Glioblastoma
55
Precursor Cell Lymphoblastic Leukemia-Lymphoma
51
Small Cell Lung Carcinoma
48
Melanoma
45
Endometrial Neoplasms
43
Disease
43
Esophageal Neoplasms
42
Hematologic Neoplasms
41
Glioma
41
Colonic Neoplasms
41
Interventions
darolutamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Non-metastatic Castration-resistant Prostate Cancer
×
1 year
×
Clear all
NCT07538843
2026-05-15
DARE
Bayer
Not yet recruiting
800 enrolled